A patient with suspected sepsis has persistent hypotension despite fluid resuscitation and is now lethargic with an oxygen saturation of 88% on room air. Which nursing intervention should be prioritized to address the patient's current clinical status?

B) Administer vasopressor support to maintain adequate perfusion.

A) Increase the rate of fluid administration to improve blood pressure.

B) Administer vasopressor support to maintain adequate perfusion.

C) Initiate high-flow oxygen therapy to improve oxygen saturation.

D) Prepare for immediate intubation to secure the airway.

A patient diagnosed with sepsis is not responding to initial fluid resuscitation and broad-spectrum antibiotics. The patient remains hypotensive with a blood pressure of 85/55 mmHg, requires oxygen supplementation due to respiratory distress, and shows signs of lethargy. Based on the current clinical findings, what should be the nurse's priority intervention?

B) Administer a vasopressor to maintain adequate perfusion.

A) Increase the rate of fluid resuscitation to improve blood pressure.

B) Administer a vasopressor to maintain adequate perfusion.

C) Prepare for immediate intubation to secure the airway.

D) Obtain another set of blood cultures before adjusting antibiotics.

A patient with sepsis is receiving norepinephrine to manage persistent hypotension. Despite stabilization of blood pressure, the patient remains lethargic. Based on these findings, what is the most appropriate nursing intervention to prioritize?

C) Prepare for endotracheal intubation and mechanical ventilation.

A) Increase the norepinephrine dosage to further elevate blood pressure.

B) Assess for signs of disseminated intravascular coagulation.

C) Prepare for endotracheal intubation and mechanical ventilation.

D) Administer a bolus of crystalloid fluid to improve perfusion.

A patient with sepsis is exhibiting signs of acute kidney injury (AKI) despite norepinephrine support. Which intervention should the nurse prioritize to address the decreased renal perfusion?

B) Administer a fluid bolus to improve intravascular volume and renal perfusion.

A) Increase the dose of norepinephrine to further elevate blood pressure.

B) Administer a fluid bolus to improve intravascular volume and renal perfusion.

C) Initiate renal replacement therapy immediately to support kidney function.

D) Adjust the ventilator settings to improve oxygenation and reduce the risk of ARDS.

A patient with sepsis has developed acute kidney injury and is on norepinephrine to maintain blood pressure. The nurse is reviewing the current treatment plan. Which intervention is most appropriate to support renal perfusion while minimizing potential complications?

C) Adjust fluid therapy based on hemodynamic monitoring and reassess norepinephrine dosing.

A) Increase the norepinephrine dosage to enhance perfusion pressure.

B) Administer a diuretic to increase urine output.

C) Adjust fluid therapy based on hemodynamic monitoring and reassess norepinephrine dosing.

D) Initiate renal replacement therapy immediately to manage acute kidney injury.

A patient with sepsis secondary to a urinary tract infection caused by Escherichia coli is experiencing deteriorating renal function and hemodynamic instability. Which intervention should the nurse prioritize to address the patient's current clinical needs?

B) Prepare the patient for continuous renal replacement therapy (CRRT).

A) Administer prescribed broad-spectrum antibiotics immediately.

B) Prepare the patient for continuous renal replacement therapy (CRRT).

C) Increase the rate of IV fluids to improve urine output.

D) Request an increase in norepinephrine dosing to stabilize blood pressure.

A patient with sepsis and renal impairment is receiving continuous renal replacement therapy (CRRT). Despite antibiotic therapy, the patient's blood pressure remains low and renal function continues to decline. Which nursing intervention should be prioritized to address the patient's hemodynamic instability?

B) Collaborate with the healthcare provider to adjust vasopressor therapy.

A) Increase the rate of intravenous fluids to improve blood pressure.

B) Collaborate with the healthcare provider to adjust vasopressor therapy.

C) Administer diuretics to enhance urine output.

D) Position the patient in Trendelenburg to promote venous return.

A patient undergoing continuous renal replacement therapy (CRRT) is now exhibiting signs of acute respiratory distress syndrome (ARDS) with hypoxemia and hypercapnia. The interdisciplinary team has initiated a lung-protective ventilation strategy. As a nurse, what is the priority intervention to evaluate the effectiveness of the ventilation strategy?

B) Assess arterial blood gas values regularly

A) Monitor the patient's urine output hourly

B) Assess arterial blood gas values regularly

C) Measure central venous pressure (CVP) every 4 hours

D) Check serum lactate levels once per shift

A patient with acute respiratory distress syndrome (ARDS) is receiving lung-protective ventilation with lower tidal volumes and increased PEEP. The patient's serum lactate level is elevated, indicating tissue hypoperfusion. Which of the following interventions should the nurse prioritize to address the patient's current condition and promote stability?

C) Collaborate with the healthcare team to adjust CRRT parameters for optimal fluid balance.

A) Increase the rate of fluid administration to improve tissue perfusion.

B) Administer a bronchodilator to enhance airway patency.

C) Collaborate with the healthcare team to adjust CRRT parameters for optimal fluid balance.

D) Initiate high-frequency oscillatory ventilation to improve oxygenation.

Sepsis - Nursing Case Study

Pathophysiology

• Primary mechanism: Sepsis begins with an overwhelming immune response to an infection, where pro-inflammatory cytokines like TNF-alpha and IL-6 are excessively released, leading to systemic inflammation and widespread tissue damage.

• Secondary mechanism: This inflammatory response causes endothelial dysfunction, resulting in increased vascular permeability and vasodilation, which lead to hypotension and impaired tissue perfusion.

• Key complication: The combination of inflammation and endothelial damage can further progress to disseminated intravascular coagulation (DIC), where abnormal clotting disrupts blood flow and contributes to multi-organ failure.

Patient Profile

Demographics:

52-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes

• Current medications: Lisinopril, Metformin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Fever and worsening shortness of breath

• Key symptoms: Chills, confusion, decreased urine output, persistent cough

• Vital signs: Temperature 39.0°C (102.2°F), Heart rate 110 bpm, Respiratory rate 24 breaths/min, Blood pressure 90/60 mmHg, Oxygen saturation 92% on room air

Section 1

As the medical team continues to monitor the patient, new diagnostic results reveal significant findings. A complete blood count shows leukocytosis with a white blood cell count of 18,000/mm³, indicating an ongoing inflammatory response. A blood culture is positive for Gram-negative bacilli, suggesting a bacterial source of infection, likely originating from an undiagnosed urinary tract infection or pneumonia, given the patient's symptoms. The chemistry panel reveals elevated lactate levels at 4 mmol/L, signaling impaired tissue perfusion and a shift towards anaerobic metabolism, which is concerning for worsening sepsis. Furthermore, the patient's creatinine level has increased to 2.3 mg/dL from a baseline of 1.1 mg/dL, indicating acute kidney injury, likely due to decreased renal perfusion.

The nursing team also notes changes in the patient's clinical status. Despite initial interventions, including fluid resuscitation and administration of broad-spectrum antibiotics, the patient's hypotension persists with a blood pressure of 85/55 mmHg. Additionally, the patient's respiratory distress has escalated, with an oxygen saturation dropping to 88% on room air, requiring supplemental oxygen via a non-rebreather mask. The patient is now more lethargic, responding only to verbal stimuli, which may suggest decreased cerebral perfusion or worsening systemic infection.

Given these developments, the clinical team must reassess and adjust the management plan. The persistence of hypotension despite fluid therapy suggests the potential need for vasopressor support to maintain adequate blood pressure and perfusion. The positive blood culture requires the adjustment of antibiotics to target the specific pathogen, while the increasing respiratory compromise necessitates consideration for more advanced airway management. The team must also closely monitor for signs of disseminated intravascular coagulation, given the patient's risk factors and current trajectory, and prepare to address any emerging complications swiftly.

Section 2

The clinical team decides to focus on the patient's persistent hypotension and respiratory compromise, given the current assessment findings. Despite the administration of 3 liters of crystalloid fluid, the patient's blood pressure remains low at 85/55 mmHg, indicating a possible need for vasopressor support. The team initiates norepinephrine at 0.05 mcg/kg/min to improve mean arterial pressure and enhance organ perfusion. Concurrently, the antibiotic regimen is adjusted based on the blood culture results, switching to ceftriaxone and gentamicin to specifically target the identified Gram-negative bacilli.

Further assessment reveals that the patient's respiratory function continues to deteriorate. With an oxygen saturation persistently hovering around 88-90% despite high-flow oxygen via a non-rebreather mask, the team considers endotracheal intubation and mechanical ventilation to ensure adequate oxygenation and reduce the work of breathing. Arterial blood gas analysis shows a pH of 7.30, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, consistent with respiratory acidosis and hypoxemia. These findings reinforce the need for advanced airway management.

In response to these interventions, the team closely monitors the patient's clinical status, noting any changes in vital signs, mental status, and laboratory values. The initiation of vasopressor therapy begins to stabilize the patient's blood pressure, with a gradual increase noted to 95/60 mmHg. However, the patient's lethargy persists, suggesting ongoing central nervous system involvement, potentially due to sepsis-induced encephalopathy. The team remains vigilant for signs of further complications, such as disseminated intravascular coagulation or multi-organ dysfunction, ready to adjust the treatment plan as the patient's condition evolves.

Section 3

As the clinical team continues to monitor the patient's response to interventions, a new complication emerges. Despite the initial improvement in blood pressure with norepinephrine, the patient begins to exhibit signs of acute kidney injury. Laboratory tests reveal an increase in serum creatinine from baseline 1.0 mg/dL to 2.5 mg/dL, and a decrease in urine output to less than 0.3 mL/kg/hr over the past 6 hours. These findings suggest that the patient's kidneys are not receiving adequate perfusion despite vasopressor support, a common complication in the setting of sepsis and systemic inflammatory response.

In response to this development, the clinical team revisits the fluid management strategy and adjusts the norepinephrine dose to optimize renal perfusion while minimizing the risk of fluid overload. Additionally, nephrology is consulted for further evaluation and potential initiation of renal replacement therapy if the patient's renal function continues to decline. The team also reassesses the patient's medication regimen, considering the nephrotoxic potential of the antibiotics being administered.

Meanwhile, the patient's respiratory status shows marginal improvement post-intubation and mechanical ventilation initiation, with a slight increase in oxygen saturation to 92%. However, the appearance of new bilateral infiltrates on a follow-up chest X-ray raises concerns about the development of acute respiratory distress syndrome (ARDS). This prompts a reassessment of the ventilator settings to ensure lung-protective strategies are employed, balancing the need for adequate oxygenation against the risk of further lung injury. The team remains vigilant, understanding that the interplay between sepsis, respiratory failure, and renal compromise requires constant re-evaluation and adjustment of the treatment plan.

Section 4

As the clinical team continues to navigate the complex presentation of sepsis and its complications, a new diagnostic result sheds light on the evolving condition of the patient. Blood cultures, which were drawn upon admission, have returned positive for Gram-negative bacilli, specifically Escherichia coli, suggesting a possible source of sepsis originating from the urinary tract. This finding prompts an adjustment in the antibiotic regimen to target this specific pathogen more effectively, thereby aiming to address the underlying infection more precisely.

Concurrently, the patient's renal function continues to deteriorate, with serum creatinine rising further to 3.0 mg/dL, and urine output decreasing to an alarming rate of less than 0.2 mL/kg/hr. Despite adjustments to the norepinephrine dosage, the hemodynamic stability remains tenuous, with blood pressure readings fluctuating between 85/50 mmHg and 90/55 mmHg. In light of these developments, the nephrology team recommends initiating continuous renal replacement therapy (CRRT) to support renal function and help manage fluid balance, especially given the risk of fluid overload due to impaired renal excretion.

These changes necessitate a comprehensive reassessment of the patient's overall management plan, emphasizing the importance of interdisciplinary collaboration. The clinical team is acutely aware of the delicate balance required between maintaining adequate organ perfusion and preventing further organ damage. They discuss the potential need for additional interventions, such as escalating vasopressor support or modifying ventilatory strategies further, to ensure optimal patient outcomes. The presence of ARDS and the risk of multi-organ failure underscore the critical need for ongoing vigilance and timely adjustments to the therapeutic approach.

Section 5

As the clinical team continues to monitor the patient's condition closely, a new development arises that further complicates the clinical picture. On the second day of continuous renal replacement therapy (CRRT), the patient begins to exhibit signs of acute respiratory distress syndrome (ARDS), with increasing difficulty in maintaining adequate oxygenation despite current ventilatory support. Arterial blood gas analysis reveals a PaO2 of 55 mmHg and a PaCO2 of 60 mmHg, indicating significant hypoxemia and hypercapnia. The patient's oxygen saturation has dropped to 88% on a FiO2 of 0.7, necessitating adjustments in ventilatory settings to optimize gas exchange and reduce the risk of ventilator-induced lung injury.

In response to these changes, the respiratory therapy team collaborates with the intensivist to initiate a lung-protective ventilation strategy, incorporating lower tidal volumes and increasing positive end-expiratory pressure (PEEP) in an attempt to improve oxygenation while minimizing further alveolar damage. Given the patient's fluctuating hemodynamics, the team carefully titrates vasopressor support, with norepinephrine doses adjusted to maintain mean arterial pressure (MAP) above 65 mmHg, ensuring adequate perfusion of vital organs despite the increased ventilatory demands.

These challenges prompt a reevaluation of the patient's fluid status and the potential for further intervention. The critical care team considers the delicate balance between aggressive resuscitation and the risk of exacerbating pulmonary edema. They vigilantly monitor the patient's central venous pressure (CVP) and serum lactate levels, which remain elevated at 4.5 mmol/L, indicating ongoing tissue hypoperfusion. This necessitates a dynamic approach to fluid management, closely coordinating with the nephrology team to adjust CRRT parameters as needed. The complexity of the situation underscores the need for continuous interdisciplinary collaboration to navigate the evolving complications and optimize the patient's chances for recovery.